These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


209 related items for PubMed ID: 19519284

  • 1. Overview of the changing epidemiology of candidemia.
    Lewis RE.
    Curr Med Res Opin; 2009 Jul; 25(7):1732-40. PubMed ID: 19519284
    [Abstract] [Full Text] [Related]

  • 2. [Nosocomial candidemia: new challenges of an emergent problem].
    Gómez J, García-Vázquez E, Hernández A, Espinosa C, Ruiz J.
    Rev Esp Quimioter; 2010 Dec; 23(4):158-68. PubMed ID: 21191553
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Candidemia in children.
    Zaoutis T.
    Curr Med Res Opin; 2010 Jul; 26(7):1761-8. PubMed ID: 20513207
    [Abstract] [Full Text] [Related]

  • 5. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG, Dralle H.
    Eur J Med Res; 2002 May 31; 7(5):200-26. PubMed ID: 12069912
    [Abstract] [Full Text] [Related]

  • 6. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May 31; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
    Hachem R, Hanna H, Kontoyiannis D, Jiang Y, Raad I.
    Cancer; 2008 Jun 31; 112(11):2493-9. PubMed ID: 18412153
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
    Klevay MJ, Horn DL, Neofytos D, Pfaller MA, Diekema DJ, PATH Alliance.
    Diagn Microbiol Infect Dis; 2009 Jun 31; 64(2):152-7. PubMed ID: 19376667
    [Abstract] [Full Text] [Related]

  • 12. Invasive Candida infections: the changing epidemiology.
    Marr KA.
    Oncology (Williston Park); 2004 Dec 31; 18(14 Suppl 13):9-14. PubMed ID: 15682589
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. New developments in the diagnosis and management of invasive fungal infections.
    De Marie S.
    Haematologica; 2000 Jan 31; 85(1):88-93. PubMed ID: 10629598
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current treatment strategies for disseminated candidiasis.
    Spellberg BJ, Filler SG, Edwards JE.
    Clin Infect Dis; 2006 Jan 15; 42(2):244-51. PubMed ID: 16355336
    [Abstract] [Full Text] [Related]

  • 18. Could risk assessment for non-albicans Candida improve empiric treatment for invasive candidiasis?
    Drew RH.
    Ann Pharmacother; 2007 Apr 15; 41(4):690-2. PubMed ID: 17389669
    [Abstract] [Full Text] [Related]

  • 19. The changing epidemiology of invasive fungal infections: new threats.
    Maschmeyer G.
    Int J Antimicrob Agents; 2006 Jun 15; 27 Suppl 1():3-6. PubMed ID: 16707250
    [Abstract] [Full Text] [Related]

  • 20. Invasive candidiasis and candidemia: new guidelines.
    De Rosa FG, Garazzino S, Pasero D, Di Perri G, Ranieri VM.
    Minerva Anestesiol; 2009 Jun 15; 75(7-8):453-8. PubMed ID: 19078900
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.